echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Amino Acids Research > Dentons Biochemicals Interim Earnings Loss

    Dentons Biochemicals Interim Earnings Loss

    • Last Update: 2020-07-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Dentons Biochemicals (00809.HK) is expected to report a loss in its half-year results by the end of this monthThe Company considers that the losses were mainly due to the decline in the price and demand of the Group's products, in particular the impact of the group's sale of lysine products on the recent emergence of the new avian influenza virus and the provision of the Group's inventory9sR
    In view of adverse market conditions, the company has implemented cost control measures, mainly through the flexible production of lysine products and the cessation of the production of chemical alcohol products9sR
    The company believes that the Group's financial position remains solidIn order to adapt to market changes and stabilize the Group's operating performance, the Group will continue to take a prudent approach to financial management and capital expenditure9sRDentons Biochemicals (00809.HK) reported a loss at the end of the monthThe Company considers that the losses were mainly due to the decline in the price and demand of the Group's products, in particular the impact of the group's sale of lysine products on the recent emergence of the new avian influenza virus and the provision of the Group's inventory9sR
    In view of adverse market conditions, the company has implemented cost control measures, mainly through the flexible production of lysine products and the cessation of the production of chemical alcohol products9sR
    The company believes that the Group's financial position remains solidIn order to adapt to market changes and stabilize the Group's operating performance, the Group will continue to take a prudent approach to financial management and capital expenditure9sR
     
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.